Market Overview

UPDATE: Ladenburg Thalmann Reduces PT on Bioanalytical Systems to $2.25


According to a research report this morning, Ladenburg Thalmann reduces its PT on Bioanalytical Systems (NASDAQ: BASI) from $2.75 to $2.25 following disappointing Q2-2012.

Ladenburg Thalmann stated, “The Company announced losing $1.86MM and $0.27 per share on revenue of $6.97MM as compared with our estimate (and consensus) of earning $480,000 and $0.07 per share on revenue of $8.88MM. The Company is planning to take a variety of steps over the next few months to reduce operating costs at the two main facilities in West Lafayette and Evansville IN which are expected to reduce operating expenses by approximately $2.5MM annually.”

Bioanalytical Systems closed yesterday at $1.11 as Ladenburg Thalmann reiterates its Buy rating.

Latest Ratings for BASI

May 2012MaintainsBuy
Feb 2012MaintainsBuy

View More Analyst Ratings for BASI
View the Latest Analyst Ratings

Posted-In: Ladenburg ThalmannAnalyst Color Reiteration Analyst Ratings


Related Articles (BASI)

View Comments and Join the Discussion!

Latest Ratings

MCDJP morganMaintains215.0
SHWJP MorganMaintains560.0
CMGJP MorganMaintains845.0
BIIBJP MorganMaintains260.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

UPDATE: Deutsche Bank Downgrades Aon PLC to Hold; No Near-Term Catalysts

FAME II Trial Demonstrates FFR-Guided PCI Superior to Medical Treatment in Preliminary Findings